Prediction models of diabetes complications: a scoping review

Background Diabetes often places a large burden on people with diabetes (hereafter ‘patients’) and the society, that is, in part attributable to its complications. However, evidence from models predicting diabetes complications in patients remains unclear. With the collaboration of patient partners, we aimed to describe existing prediction models of physical and mental health complications of diabetes. Methods Building on existing frameworks, we systematically searched for studies in Ovid-Medline and Embase. We included studies describing prognostic prediction models that used data from patients with pre-diabetes or any type of diabetes, published between 2000 and 2020. Independent reviewers screened articles, extracted data and narratively synthesised findings using established reporting standards. Results Overall, 78 studies reported 260 risk prediction models of cardiovascular complications (n=42 studies), mortality (n=16), kidney complications (n=14), eye complications (n=10), hypoglycaemia (n=8), nerve complications (n=3), cancer (n=2), fracture (n=2) and dementia (n=1). Prevalent complications deemed important by patients such as amputation and mental health were poorly or not at all represented. Studies primarily analysed data from older people with type 2 diabetes (n=54), with little focus on pre-diabetes (n=0), type 1 diabetes (n=8), younger (n=1) and racialised people (n=10). Per complication, predictors vary substantially between models. Studies with details of calibration and discrimination mostly exhibited good model performance. Conclusion This rigorous knowledge synthesis provides evidence of gaps in the landscape of diabetes complication prediction models. Future studies should address unmet needs for analyses of complications n> and among patient groups currently under-represented in the literature and should consistently report relevant statistics. Scoping review registration https://osf.io/fjubt/

[1]  V. Mohan,et al.  Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses , 2020, Diabetologia.

[2]  P. Kent,et al.  A conceptual framework for prognostic research , 2020, BMC Medical Research Methodology.

[3]  Catherine H. Yu,et al.  Predictive models of diabetes complications: protocol for a scoping review , 2020, Systematic Reviews.

[4]  V. Regitz-Zagrosek,et al.  Impact of sex and gender on COVID-19 outcomes in Europe , 2020, Biology of Sex Differences.

[5]  F. Schellevis,et al.  Mismatch between self-perceived and calculated cardiometabolic disease risk among participants in a prevention program for cardiometabolic disease: a cross-sectional study , 2020, BMC Public Health.

[6]  M. Pencina,et al.  Prediction Models - Development, Evaluation, and Clinical Application. , 2020, The New England journal of medicine.

[7]  H. Witteman,et al.  Patients’ perspectives on how to improve diabetes care and self-management: qualitative study , 2020, BMJ Open.

[8]  N. Wong,et al.  Development of a Risk Score for Atrial Fibrillation in Adults With Diabetes Mellitus (from the ACCORD Study). , 2020, The American journal of cardiology.

[9]  M. Kattan,et al.  Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach , 2020, Diabetes Care.

[10]  I. Khalil,et al.  Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes , 2020, Diabetes Therapy.

[11]  Jun Lyu,et al.  A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China , 2020, Acta Diabetologica.

[12]  L. H. Nguyen,et al.  Effects of Diabetic Complications on Health-Related Quality of Life Impairment in Vietnamese Patients with Type 2 Diabetes , 2020, Journal of diabetes research.

[13]  Arnaub K Chatterjee,et al.  A randomized study on the usefulness of an electronic outpatient hypoglycemia risk calculator for clinicians of patients with diabetes in a safety-net institution , 2020, Current medical research and opinion.

[14]  M. Woodward,et al.  Sex differences in the risk of vascular disease associated with diabetes , 2020, Biology of Sex Differences.

[15]  Richard J Stevens,et al.  Validation of clinical prediction models: what does the "calibration slope" really measure? , 2020, Journal of clinical epidemiology.

[16]  B. Williams,et al.  A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus , 2019, Clinical cardiology.

[17]  Oscar Barquero-Perez,et al.  Pulse Wave Velocity and Machine Learning to Predict Cardiovascular Outcomes in Prediabetic and Diabetic Populations , 2019, Journal of Medical Systems.

[18]  G. Fagherazzi,et al.  Socioeconomic inequalities and type 2 diabetes complications: A systematic review. , 2019, Diabetes & metabolism.

[19]  Yamei Cai,et al.  Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study , 2019, BMJ Open Diabetes Research & Care.

[20]  V. Fuster,et al.  Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease. , 2019, Journal of the American College of Cardiology.

[21]  Eli M Cahan,et al.  Putting the data before the algorithm in big data addressing personalized healthcare , 2019, npj Digital Medicine.

[22]  J. Duke,et al.  Predictive modeling of hypoglycemia for clinical decision support in evaluating outpatients with diabetes mellitus , 2019, Current medical research and opinion.

[23]  S. Kitto,et al.  Protocol for a systematic scoping review of reasons given to justify the performance of randomised controlled trials , 2019, BMJ Open.

[24]  B. Shah,et al.  Derivation and Validation of a Risk-Prediction Tool for Hypoglycemia in Hospitalized Adults With Diabetes: The Hypoglycemia During Hospitalization (HyDHo) Score. , 2019, Canadian journal of diabetes.

[25]  Lizheng Shi,et al.  Correction to: Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO) , 2019, PharmacoEconomics.

[26]  Hetal S. Shah,et al.  EstimatioN oF mORtality risk in type2 diabetiC patiEnts (ENFORCE): an inexpensive and parsimonious prediction model. , 2019, The Journal of clinical endocrinology and metabolism.

[27]  B. J. Klevering,et al.  Validation of a model for the prediction of retinopathy in persons with type 1 diabetes , 2019, British Journal of Ophthalmology.

[28]  B. Davis,et al.  Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus. , 2019, European heart journal.

[29]  C. Joseph,et al.  Systematic scoping review protocol for clinical prediction rules (CPRs) in the management of patients with spinal cord injuries , 2019, BMJ Open.

[30]  M. García-Fiñana,et al.  Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules , 2018, Diabetes, obesity & metabolism.

[31]  Catherine H. Yu,et al.  Diabetes Canada 2018 clinical practice guidelines: Key messages for family physicians caring for patients living with type 2 diabetes. , 2019, Canadian family physician Medecin de famille canadien.

[32]  G. Collins,et al.  PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies , 2019, Annals of Internal Medicine.

[33]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[34]  Kyungdo Han,et al.  Development and validation of a risk prediction model for severe hypoglycemia in adult patients with type 2 diabetes: a nationwide population-based cohort study , 2018, Clinical epidemiology.

[35]  G. Collins,et al.  Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort , 2018, PloS one.

[36]  J. Shaw,et al.  Global trends in diabetes complications: a review of current evidence , 2018, Diabetologia.

[37]  Björn Eliasson,et al.  Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes , 2018, The New England journal of medicine.

[38]  F. Lo,et al.  Nomogram for prediction of non-proliferative diabetic retinopathy in juvenile-onset type 1 diabetes: a cohort study in an Asian population , 2018, Scientific Reports.

[39]  E. Seaquist,et al.  Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes , 2018, BMJ Open Diabetes Research & Care.

[40]  Chia-Ing Li,et al.  Development and validation of prediction models for the risks of diabetes-related hospitalization and in-hospital mortality in patients with type 2 diabetes. , 2018, Metabolism: clinical and experimental.

[41]  F. Agakov,et al.  Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes. , 2018, Atherosclerosis.

[42]  M. Kumar,et al.  Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. , 2018, Clinical therapeutics.

[43]  Chia-Ing Li,et al.  Establishment and validation of a prediction model for ischemic stroke risks in patients with type 2 diabetes. , 2018, Diabetes research and clinical practice.

[44]  Riccardo Bellazzi,et al.  Machine Learning Methods to Predict Diabetes Complications , 2018, Journal of diabetes science and technology.

[45]  N. Ernstmann,et al.  Information needs in people with diabetes mellitus: a systematic review , 2018, Systematic Reviews.

[46]  E. Wan,et al.  Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population‐based retrospective cohort study , 2018, Diabetes, obesity & metabolism.

[47]  H. Witteman,et al.  Diabetes‐related complications: Which research topics matter to diverse patients and caregivers? , 2017, Health Expectations.

[48]  M. Coons,et al.  Diabetes and Mental Health. , 2018, Canadian journal of diabetes.

[49]  Catherine B. Chan,et al.  Nutrition Therapy Diabetes Canada Clinical Practice Guidelines Expert Committee , 2018 .

[50]  D. Grobbee,et al.  Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes , 2018, Diabetes & vascular disease research.

[51]  S. Basu,et al.  Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S. , 2017, Diabetes Care.

[52]  Donald R. Miller,et al.  Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital Use , 2017, JAMA internal medicine.

[53]  S. Basu,et al.  Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials. , 2017, The lancet. Diabetes & endocrinology.

[54]  Thomas Stoll,et al.  Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II , 2017, Diabetes Care.

[55]  E. Wan,et al.  Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study , 2017, BMC Nephrology.

[56]  J. Steiner,et al.  Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: Development and external validation of a prediction model. , 2017, Journal of diabetes and its complications.

[57]  E. Wan,et al.  Prediction of five-year all-cause mortality in Chinese patients with type 2 diabetes mellitus - A population-based retrospective cohort study. , 2017, Journal of diabetes and its complications.

[58]  C. Yap,et al.  HbA1c variability in type 2 diabetes is associated with the occurrence of new-onset albuminuria within three years. , 2017, Diabetes research and clinical practice.

[59]  A. Rustgi,et al.  A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes. , 2017, Gastroenterology.

[60]  R. Hamman,et al.  Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood , 2017, JAMA.

[61]  Yu Qin,et al.  Development and Validation of a Model for Predicting Diabetic Nephropathy in Chinese People. , 2017, Biomedical and environmental sciences : BES.

[62]  R. Emsley,et al.  Life Expectancy and Cause-Specific Mortality in Type 2 Diabetes: A Population-Based Cohort Study Quantifying Relationships in Ethnic Subgroups , 2016, Diabetes Care.

[63]  N. Stone,et al.  What to say and how to say it: effective communication for cardiovascular disease prevention , 2016, Current opinion in cardiology.

[64]  J. Spertus,et al.  Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus , 2016, Circulation. Cardiovascular quality and outcomes.

[65]  M. Jørgensen,et al.  Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine , 2016, Circulation.

[66]  J. Hippisley-Cox,et al.  Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study , 2015, BMJ Open.

[67]  G. Heinze,et al.  Risk Prediction for Early CKD in Type 2 Diabetes. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[68]  C. Elley,et al.  Development and validation of a predictive risk model for all-cause mortality in type 2 diabetes. , 2015, Diabetes research and clinical practice.

[69]  L. Strycker,et al.  Understanding the sources of diabetes distress in adults with type 1 diabetes. , 2015, Journal of diabetes and its complications.

[70]  F. Agakov,et al.  Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes , 2015, Diabetologia.

[71]  D. Moher,et al.  Scoping reviews: time for clarity in definition, methods, and reporting. , 2014, Journal of clinical epidemiology.

[72]  G. Collins,et al.  Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist , 2014, PLoS medicine.

[73]  M. Budoff,et al.  Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. , 2014, Atherosclerosis.

[74]  I. Irigoien,et al.  Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: The Basque Country Prospective Complications and Mortality Study risk engine (BASCORE) , 2014, Diabetologia.

[75]  M. Rewers,et al.  Predicting major outcomes in type 1 diabetes: a model development and validation study , 2014, Diabetologia.

[76]  L. Hooper,et al.  Accuracy of prediction equations for serum osmolarity in frail older people with and without diabetes , 2014, The American journal of clinical nutrition.

[77]  O. Dekkers,et al.  Predicting Mortality in Patients with Diabetes Starting Dialysis , 2014, PloS one.

[78]  W. Katon,et al.  Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. , 2013, The lancet. Diabetes & endocrinology.

[79]  Sherita Hill Golden,et al.  Race/Ethnic Difference in Diabetes and Diabetic Complications , 2013, Current Diabetes Reports.

[80]  C. Elley,et al.  Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes , 2013, Diabetes Care.

[81]  M. Copetti,et al.  Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes , 2013, Diabetes Care.

[82]  V. Lagani,et al.  A systematic review of predictive risk models for diabetes complications based on large scale clinical studies. , 2013, Journal of diabetes and its complications.

[83]  K. Moons,et al.  Diagnostic and prognostic prediction models , 2013, Journal of thrombosis and haemostasis : JTH.

[84]  Atsushi Araki,et al.  Predicting Macro- and Microvascular Complications in Type 2 Diabetes , 2013, Diabetes Care.

[85]  Richard Cairns,et al.  A clinical risk score for heart failure in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study. , 2013, International journal of cardiology.

[86]  D. Siscovick,et al.  Prediction and classification of cardiovascular disease risk in older adults with diabetes , 2013, Diabetologia.

[87]  P. Metcalf,et al.  New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort. , 2012, Journal of primary health care.

[88]  S. Dutta,et al.  Diabetic Complications: Current Challenges and Opportunities , 2012, Journal of Cardiovascular Translational Research.

[89]  Carol M. Mangione,et al.  Predictors of Mortality Over 8 Years in Type 2 Diabetic Patients , 2012, Diabetes Care.

[90]  T. Wilt,et al.  Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes - A Systematic Review of the Evidence , 2012 .

[91]  J. Bergold,et al.  Participatory Research Methods: A Methodological Approach in Motion , 2012 .

[92]  St. Jean,et al.  Information Behavior of People Diagnosed with a Chronic Serious Health Condition: A Longitudinal Study , 2012 .

[93]  K G M Moons,et al.  Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review , 2011, Heart.

[94]  Angelina Kouroubali,et al.  Risk Assessment Models for Diabetes Complications: A Survey of Available Online Tools , 2011, MobiHealth.

[95]  S. Gudbjörnsdottir,et al.  A new model for 5‐year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR) , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[96]  N. Jewell,et al.  Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy. , 2011, Investigative ophthalmology & visual science.

[97]  S. Gudbjörnsdottir,et al.  A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR). , 2011, Diabetes research and clinical practice.

[98]  G. Zarini,et al.  The Healthy Eating Index and the Alternate Healthy Eating Index as predictors of 10-year CHD risk in Cuban Americans with and without type 2 diabetes , 2011, Public Health Nutrition.

[99]  S. Haneuse,et al.  Designs for the Combination of Group- and Individual-level Data , 2011, Epidemiology.

[100]  J. Gross,et al.  Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes , 2011, Diabetes Care.

[101]  Mark Woodward,et al.  Contemporary model for cardiovascular risk prediction in people with type 2 diabetes , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[102]  N. Jewell,et al.  Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. , 2011, Investigative Ophthalmology and Visual Science.

[103]  W. Brown Framingham Heart Study. , 2011, Journal of clinical lipidology.

[104]  N. Chaturvedi,et al.  Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model. , 2010, Diabetes research and clinical practice.

[105]  M W Knuiman,et al.  An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study , 2010, Internal medicine journal.

[106]  C. Raina Elley,et al.  Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes , 2010, Diabetes Care.

[107]  N. Obuchowski,et al.  Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.

[108]  M. Rewers,et al.  Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule , 2009, Diabetologia.

[109]  R. Mccallum,et al.  Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study , 2009, The Medical journal of Australia.

[110]  Ruth Williams Patients' perspectives. , 2009, Nursing management.

[111]  Björn Eliasson,et al.  Risk Prediction of Cardiovascular Disease in Type 2 Diabetes , 2008, Diabetes Care.

[112]  Xilin Yang,et al.  Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. , 2008, Endocrine-related cancer.

[113]  Xilin Yang,et al.  Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus , 2008, Cardiovascular diabetology.

[114]  Xilin Yang,et al.  Development and validation of an all-cause mortality risk score in type 2 diabetes. , 2008, Archives of internal medicine.

[115]  Xilin Yang,et al.  Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. , 2008, The American journal of cardiology.

[116]  Jan P Vandenbroucke,et al.  Observational Research, Randomised Trials, and Two Views of Medical Science , 2008, PLoS medicine.

[117]  A. Kong,et al.  Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry , 2008 .

[118]  Vivian Wong,et al.  Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes , 2007, Diabetes Care.

[119]  A. Kong,et al.  End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry , 2006, Diabetologia.

[120]  Gretchen A. Piatt,et al.  Deficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[121]  Ying Zhang,et al.  Prediction of Coronary Heart Disease in a Population With High Prevalence of Diabetes and Albuminuria: The Strong Heart Study , 2006, Circulation.

[122]  V. Montori,et al.  A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes. , 2006, Mayo Clinic proceedings.

[123]  K. Donaghue,et al.  Complications of diabetes mellitus in childhood. , 2005, Pediatric clinics of North America.

[124]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[125]  C. Byrne,et al.  Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[126]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[127]  R. Stevens,et al.  UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine , 2002, Stroke.

[128]  R. Holman,et al.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.

[129]  A. Karter,et al.  Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. , 2001, Diabetes care.

[130]  W. Spitzer Meta-meta-analysis: unanswered questions about aggregating data. , 1991, Journal of clinical epidemiology.